August 6, 2013

Mobile pharmacy technology company Mscripts has launched Web Pharmacy, which will allow pharmacies to offer patients an integrated and branded web and mobile environment to manage their health and prescription needs, the company said Tuesday.

August 6, 2013

“We're asking the pharmacists to be proactive in their communication rather than reactive.”

That’s Andrew Markievich, manager of pharmacy clinical programs for Ahold USA, the big Dutch-based owner-operator of U.S. supermarket chains like Stop & Shop and Giant Food in the Northeast and mid-Atlantic region. Speaking to Drug Store News’ Alaric DeArment, Markievich was describing a new campaign at Ahold USA’s more than 560 food-store pharmacies “to take a more active, deliberate role in communicating with our patients.”

August 6, 2013

Canadian pharmacy retailer Rexall has announced the launch of MyRexall, providing its customers with the ability to view and print their personal medication records online at Rexall.ca.

August 5, 2013

Express Scripts and Walgreens last week announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs and to help drive lower costs. The program is expected to improve medication adherence by both providing a cost value to the patient while maintaining what has more and more become a crucial patient-pharmacist face-to-face encounter.

What a difference a year makes. Far removed from its squabbles over reimubursement, the two companies partner on a new program that reinforces the value that retail pharmacy provides and the innovative ways that retail and mail can work together to create solutions that help get patients on, and keep them on, their medications.

August 2, 2013

U.S. Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., on Thursday introduced legislation that would retool the labeling requirements for dietary supplement manufacturers, require pre-market certification on new products and require successful efficacy trials.

August 1, 2013

A new app allows patients to communicate through audio and video with their pharmacies using a smartphone, tablet or computer.

August 1, 2013

Sanofi Wednesday evening announced that the Food and Drug Administration's Nonprescription Drugs Advisory Committee voted 10-6 in favor of its switch application of the nasal corticosteroid Nasacort AQ. Two committee members abstained.

August 1, 2013

Emdeon has given pharmacy automation products maker QS/1 certification for electronic prescriptions of controlled substances, or EPCS, QS/1 said Thursday.

August 1, 2013

Express Scripts and Walgreens announced the launch of Smart90 Walgreens, a new option for Express Scripts clients interested in 90-day prescription drug programs that helps drive lower costs.

July 31, 2013

The Food and Drug Administration has approved a Perrigo generic drug for treating dermatitis, the company said Wednesday.

July 31, 2013

The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.

July 31, 2013

Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.

July 30, 2013

Attendees of this year’s Cardinal Health Retail Business Conference will choose 1-of-3 finalists of a special best practice competition to determine the most innovative independent pharmacy program among Cardinal Health customers.

July 30, 2013

Hisamitsu America, the manufacturer of Salonpas, an OTC pain patch that is FDA approved and clinically proven, announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

July 29, 2013

Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.

July 29, 2013

The Consumer Healthcare Products Association endorsed the Restoring Access to Medication Act (H.R. 2835), which would repeal a requirement enacted into law as part of the Patient Protection and Affordable Care Act of 2010 that requires consumers to obtain a prescription in order to utilize their flexible spending arrangements and health savings accounts to purchase over-the-counter medicines.

July 29, 2013

Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.

July 29, 2013

Drug maker Pfizer is planning to split its commercial division into three business lines that will separate its branded and generic products, the company said Monday.

July 26, 2013

A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

July 26, 2013

Pharmacists at Good Neighbor Pharmacy can provide immunizations to patients without a prescription from a physician under a new program, parent company AmerisourceBergen Drug Corp. said.

July 25, 2013

CNNMoney on Thursday featured a Q&A with Greg Wasson, Walgreens president CEO, to talk about how health care is transforming and how Walgreens is rethinking what it means to be a drug store in what will become a new healthcare paradigm with the implementation of the Patient Protection and Affordable Care Act in January.

July 24, 2013

Prior-authorization software company CoverMyMeds reached a milestone Tuesday as the 5 millionth PA request was sent through its system.

July 24, 2013

The Food and Drug Administration has granted the manufacturer of Plan B One-Step exclusive marketing rights for three years, according to published reports.